ACHE and Mental deterioration: The depletion or malfunction of these components has been reported in individuals experiencing cognitive decline, leading to the evaluation of whether drug candidates can affect the abundance and availability of Ch and the activity of AChE and ChAT, and elicit agonistic effects at ACh receptors [2–6].